Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinman Zhong

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Drug Design, Development and Therapy|July 1, 2026
Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal HemoglobinuriaChang Chen, Jinman Zhong, Dan Xiong
Cancer Biology & Therapy|May 26, 2026
Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progressionJinman Zhong, Yanmeng Deng, Xingru Qin, et al.
Archives of Medical Science : AMS|June 17, 2026
Combining the PI-RADS v2.1 score with PSAD improves the diagnostic accuracy of transition zone prostate cancerJinman Zhong, Jianke Ding, Yuelang Zhang, et al.
Frontiers in Oncology|November 15, 2024
TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case reportChang Chen, Jinman Zhong, Wanzhen Hu, et al.
Drug Design, Development and Therapy|March 25, 2024
A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEXJinman Zhong, Duoduo Liu, Quanxin Yang, et al.
Annals of Hematology|March 12, 2021
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantationXiaoyin Bu, Jinman Zhong, Weiru Li, et al.
The British Journal of Radiology|January 8, 2026
Zonal origin combined with IVIM parameters could predict ISUP risk groups of prostate cancerJinman Zhong, Zhiwen Che, Xingru Qin, et al.
Frontiers in Pharmacology|August 27, 2025
Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERSJinman Zhong, Chang Chen, Yunman Xu, et al.
Oncology Letters|July 11, 2019
A DNA aptamer recognizing MMP14 for <i>in vivo</i> and <i>in vitro</i> imaging identified by cell-SELEXXufang Huang, Jinman Zhong, Jing Ren, et al.
Frontiers in Immunology|October 6, 2025
Single-cell profiling uncovers PTPRG-driven stemness in malignant plasma cells and signatures of treatment failure in multiple myelomaJiewen Tan, Jinman Zhong, Yueping He, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Drug Design, Development and Therapy|July 1, 2026
Beyond Terminal Blockade: A Mechanism-Based Approach to Complement Inhibitor Selection in Paroxysmal Nocturnal HemoglobinuriaChang Chen, Jinman Zhong, Dan Xiong
Cancer Biology & Therapy|May 26, 2026
Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progressionJinman Zhong, Yanmeng Deng, Xingru Qin, et al.
Archives of Medical Science : AMS|June 17, 2026
Combining the PI-RADS v2.1 score with PSAD improves the diagnostic accuracy of transition zone prostate cancerJinman Zhong, Jianke Ding, Yuelang Zhang, et al.
Frontiers in Oncology|November 15, 2024
TIPIC syndrome in a patient following sorafenib treatment for acute myeloid leukemia: a rare case reportChang Chen, Jinman Zhong, Wanzhen Hu, et al.
Drug Design, Development and Therapy|March 25, 2024
A Novel DNA Aptamer Probe Recognizing Castration Resistant Prostate Cancer in vitro and in vivo Based on Cell-SELEXJinman Zhong, Duoduo Liu, Quanxin Yang, et al.
Annals of Hematology|March 12, 2021
Immunomodulating functions of human leukocyte antigen-G and its role in graft-versus-host disease after allogeneic hematopoietic stem cell transplantationXiaoyin Bu, Jinman Zhong, Weiru Li, et al.
The British Journal of Radiology|January 8, 2026
Zonal origin combined with IVIM parameters could predict ISUP risk groups of prostate cancerJinman Zhong, Zhiwen Che, Xingru Qin, et al.
Frontiers in Pharmacology|August 27, 2025
Viral infections and related fatal adverse events associated with complement inhibitors for PNH: a real-world pharmacovigilance analysis in FAERSJinman Zhong, Chang Chen, Yunman Xu, et al.
Oncology Letters|July 11, 2019
A DNA aptamer recognizing MMP14 for <i>in vivo</i> and <i>in vitro</i> imaging identified by cell-SELEXXufang Huang, Jinman Zhong, Jing Ren, et al.
Frontiers in Immunology|October 6, 2025
Single-cell profiling uncovers PTPRG-driven stemness in malignant plasma cells and signatures of treatment failure in multiple myelomaJiewen Tan, Jinman Zhong, Yueping He, et al.
Pageof 3